A Phase II, Randomized, Prospective, Double blind, Parallel group, Multi-center Study to determine the Safety and Efficacy of GRANEXIN GEL in the Treatment of Diabetic Foot Ulcers
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2016
At a glance
- Drugs ACT 1 (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- 15 Jul 2013 Positive data will be reported at the International Gap Junction Conference (IGJC), according to a FirstString media release. Top-line data were reported in the media release.
- 15 Jul 2013 Primary endpoint 'Wound-closure' has been met, according to a FirstString media release.
- 24 Jul 2012 Actual initiation date changed from 7 Sep 2011 to 7 Oct 2011 as reported by Clinical Trials Registry - India.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History